LYCOS RETRIEVER 
Japan: Companies
built 621 days ago
Japan is the world leader in high-tech toilets, and its biggest toilet company, Toto, is working on a home model that will chemically analyze urine. Already selling well are toilets that clean themselves, have coatings that resist germs and spray pulsating water to massage your backside.
Source:
During the early 50s America's attitude toward Japan began to change and so did its policies. Shortly after the peace treaty was signed in 1951, Japan's antitrust laws were revised to make it easier for companies to merge and once again allowed interlocking directorates. The result was the gradual reappearance of the zaibatsu but in a slightly different form. Instead of being under the control of a single family, many of the new zaibatsu were industrial and bankcentered groups. Cooperation between members of a group ranged from sharing information concerning technological developments and pricing strategies to interdependent financial transactions and the joint development of new business lines. The resurgence of the zaibatsu occurred at a time when Japan was beginning to expand its markets overseas.
Source:
"We are excited to have a leading multi-national pharmaceutical company in Japan with one of the highest and most aggressive sales records in the Japanese market as our commercialization partner for indiplon. Importantly, DSP has a proven track record, which we believe will optimize indiplon's full potential in the growing Japanese insomnia market," said Gary Lyons, President and Chief Executive Officer of Neurocrine Biosciences, "the economics of this agreement, given the significant milestones and substantial royalty rate, confirm the value of indiplon."
Source:
Schering-Plough disclosure notice: The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the potential market for CLARITIN in Japan. Forward-looking statements relate to expectations or forecasts of future events. Schering- Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering- Plough's forward-looking statements, including market forces, economic factors, product availability, current and future branded, generic or over- the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Item 8.01 of the Company's 8-K filed on October 22, 2007.
Source:
The new Napster OTA service will be available to DoCoMo's iMode subscribers via the soon-to-be-released 904i series of handsets, as announced today in Japan by DoCoMo. Napster's OTA music subscription service is an extension of the company's award-winning Napster To Go PC service, which enables unlimited downloading and transfer of tracks for one low monthly fee to compatible portable digital music devices and cell phones. Napster's new OTA subscription functionality will be available to DoCoMo's customers as an extension of the Napster To Go service at no additional cost and will be available to both new and current Napster To Go customers.
Source:
FRAMINGHAM, MA, April 8, 2002 /PRNewswire/ -- Genzyme Transgenics Corporation (Nasdaq: GZTC) ("GTC") announced today that Fresenius AG has exercised an option to gain additional rights to market recombinant human serum albumin (rhSA) in Japan. Fresenius has paid GTC $1.2 million for these rights in accordance with the terms of the cooperation agreement between the two companies. Under this ongoing agreement, Fresenius already has similar marketing rights to rhSA in Europe, North America and the rest of Asia.
Source:
MORE ABOUT
Companies